Medical Evaluation

When a woman experiences concerning symptoms, a pelvic exam, including a rectovaginal exam, and a general physical exam should be performed. If the exam is abnormal, women should undergo a transvaginal or pelvic ultrasound to evaluate the ovaries.

If the exam is normal, it is reasonable to wait 2–3 weeks to see if the symptoms resolve. If they do not, then a transvaginal or pelvic ultrasound should be performed. If an abnormality of the ovaries is found, additional radiographic studies, such as a CT scan or MRI, and a blood test for CA 125, may be performed. CA 125 is elevated in approximately 80 percent of women with advanced stage epithelial ovarian cancer, but elevations can occur for reasons other than ovarian cancer. If you suspect or have been diagnosed with ovarian cancer, it is important to see a gynecologic oncologist. For more information about CA 125, read a brochure developed by Foundation for Women’s Cancer “Understanding CA 125 Levels: A Patient’s Guide.”

Spotlight

Community outreach played an important role in the 2018 Society of Gynecologic Oncology Annual Meeting on Women’s Cancer, held March 24-27 in New Orleans.

Awareness

September is Gynecologic Cancer Awareness Month.  After creating the month in 1999, the Foundation strives to bring attention about these cancers through public awareness campaigns.

Research

The Foundation is proud to offer various Research Grants and Awards. Click here for more information.

Education

FREE Gynecologic Cancer Survivors Courses throughout the country. For more information, click here.